Merck's tactics with statin shows how brand companies are upping the ante to retain market share
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Frantz, S. Pharma companies becoming more aggressive towards generics firms. Nat Rev Drug Discov 5, 619–620 (2006). https://doi.org/10.1038/nrd2121
Issue Date:
DOI: https://doi.org/10.1038/nrd2121
This article is cited by
-
Generika in Österreich 2003–2008: ein Update
Wiener klinische Wochenschrift (2008)